Sensorion SA (EPA:ALSEN)
France · Delayed Price · Currency is EUR 0.3500
-0.0250 (-6.67%)
Jan 30, 2026, 5:36 PM CET
Sensorion Revenue
Sensorion had revenue of 2.33M EUR in the half year ending June 30, 2025, a decrease of -8.89%. This brings the company's revenue in the last twelve months to 5.65M, down -12.79% year-over-year. In the year 2024, Sensorion had annual revenue of 6.65M with 16.76% growth.
Revenue (ttm)
5.65M
Revenue Growth
-12.79%
P/S Ratio
18.61
Revenue / Employee
83.06K
Employees
68
Market Cap
105.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.65M | 955.00K | 16.76% |
| Dec 31, 2023 | 5.70M | 764.35K | 15.49% |
| Dec 31, 2022 | 4.93M | 669.94K | 15.71% |
| Dec 31, 2021 | 4.26M | 1.91M | 81.27% |
| Dec 31, 2020 | 2.35M | -104.59K | -4.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 70.36M |
| Genfit | 45.13M |
| Adocia | 12.88M |
| Fermentalg | 12.78M |
| Innate Pharma | 12.64M |
| Transgene | 7.58M |
| ABIONYX Pharma | 4.33M |
| MaaT Pharma | 3.92M |
Sensorion News
- 4 months ago - Sensorion reports 1H results - Seeking Alpha
- 11 months ago - Sensorion reports FY results - Seeking Alpha